Patents by Inventor Yoshihiro Shidoji

Yoshihiro Shidoji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activators of peroxisome proliferator-activated receptors
    Patent number: 8017652
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14 -hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: September 13, 2011
    Assignees: Kowa Company Ltd., Nagasaki Prefectural and Municipal Universities Corporation
    Inventors: Yoshihiro Shidoji, Naoto Ishibashi
  • ACTIVATORS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
    Publication number: 20090264529
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Application
    Filed: May 8, 2009
    Publication date: October 22, 2009
    Applicants: KOWA COMPANY, LTD., NAGASAKI PREFECTURAL AND MUNICIPAL UNIVERSITIES CORPORATION
    Inventors: Yoshihiro SHIDOJI, Naoto ISHIBASHI
  • Activators of peroxisome proliferator-activated receptors
    Patent number: 7547730
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Grant
    Filed: August 27, 2007
    Date of Patent: June 16, 2009
    Assignees: Kowa Company, Ltd., Nagasaki Prefectural and Municipal Universities Corporation
    Inventors: Yoshihiro Shidoji, Naoto Ishibashi
  • ACTIVATORS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
    Publication number: 20080119553
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Application
    Filed: August 27, 2007
    Publication date: May 22, 2008
    Applicants: NIKKEN CHEMICALS CO., LTD., Nagasaki Prefectural and Municipal Universities Corporation
    Inventors: Yoshihiro SHIDOJI, Naoto ISHIBASHI
  • Activators of peroxisome proliferator-activated receptors
    Publication number: 20060063838
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Application
    Filed: November 15, 2005
    Publication date: March 23, 2006
    Applicants: Nikken Chemicals Co., Ltd., Nagasaki Prefectural Government
    Inventors: Yoshihiro Shidoji, Naoto Ishibashi
  • Activators of peroxisome proliferator-activated receptor
    Publication number: 20050250671
    Abstract: Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, as an active ingredient, and medicaments for preventive and/or therapeutic treatment of hyperlipidemia, non-insulin dependent diabetes mellitus or the like comprising a polyprenyl compound as an active ingredient.
    Type: Application
    Filed: April 23, 2001
    Publication date: November 10, 2005
    Inventors: Yoshihiro Shidoji, Naoto Ishibashi